Viewing Study NCT04494503


Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2025-12-29 @ 11:49 PM
Study NCT ID: NCT04494503
Status: RECRUITING
Last Update Posted: 2025-04-16
First Post: 2020-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module